DR Congo approves “MANACOVID” as anti-covid drug
MANACOVID was extracted from local medicinal plants.
ADVERTISEMENT
The Luozi pharmaceutical research centre (CRPL), on Tuesday approved the “MANACOVID” drug to treat the coronavirus (COVID-19) in DR Congo.
A statement issued in Kinshasa said the results were observed by three teams of doctors on 300 cases that tested positive to COVID-19.
All these cases proved negative with the disappearance of symptoms and a good tolerance, within five days of treatment or 100 per cent recovery.
Approved on November 24, 2020, with a certificate of invention as evidence, “MANACOVID” is a product based on local medicinal plants.
It was discovered in March 2020 by Congolese chemist-doctor, Etienne Flaubert Batangu Mpesa, following his work with a team of pharmacist researchers, the statement said.
Coronavirus: DR Congo approves ‘MANACOVID’ as anti-covid drug
On
Kindly Share This Story:
The Luozi pharmaceutical research centre (CRPL), on Tuesday approved the “MANACOVID” drug to treat the coronavirus (COVID-19) in DR Congo.
A statement issued in Kinshasa said the results were observed by three teams of doctors on a total of 300 cases that tested positive to COVID-19.
All these cases proved negative with the disappearance of symptoms and good tolerance, within five days of treatment or 100 per cent recovery.
Approved on 24 November, 2020, with a certificate of invention as evidence, “MANACOVID” is a product based on local medicinal plants.
It was discovered in March 2020 by Congolese chemist-doctor, Etienne Flaubert Batangu Mpesa, following his work with a team of pharmacist researchers, the statement said.
DR Congo approves MANACOVID as anti-covid drug today.ng - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from today.ng Daily Mail and Mail on Sunday newspapers.